Abstract:Objective To construct human Oct3/4 eukaryotic expression vectors and transfect human ovarian cancer cell line SKOV3,and observe the expression of Oct3/4 in SKOV3 cells.Methods Destination gene(Oct3/4) cDNA products were obtained by amplification with RT-PCR.Human recombinant Oct3/4 eukaryotic expression vectors pcDNA3.1-Oct3/4 were constructed by pcDNA3.1 vector plasmid,and were identified by restriction enzyme digestion and DNA sequence analysis.Recombinant plasmid was transfected into SKOV3 cells with Lipofectamine 2000,and SKOV3 cells transfected with empty vectors and those without transfection were served as transfection control group and negative control group,respectively.Stable transfection cells were screened by G418(neomycin),and Western blotting was employed to detect the relative expression of Oct3/4 protein in cells.Results Destination gene amplified by PCR was about 1 000 bp in length analysed by 12 g/L agarose gel electrophoresis,which met the expectancy.Human recombinant Oct3/4 eukaryotic expression plasmid vectors pcDNA3.1-Oct3 /4 were constructed,and the result of DNA sequencing was consistent with that of GenBank.Western blotting analysis revealed that the relative expression of Oct3/4 protein in stable pcDNA3.1-Oct3/4 transfected cells(10.225 ± 0.987) was significantly higher than that in transfection control group(1.713 ± 0.896) and negative control group(1 for calibration value)(P 0.01).Conclusion Human recombinant Oct3/4 eukaryotic expression vectors were successfully constructed,SKOV3 was transfected,and Oct3/4 protein is stably overexpressed in stable transfected cells,which lays a foundation for the further study of roles of Oct3/4 gene in ovarian cancer development and drug-resistance to chemotherapy.

Construction of the Eukaryotic Expression Vector Pires2-Egfp-p93 and Its Expression in Ovarian Cancer Cell Line HO-8910

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction of human recombinant Oct3/4 eukaryotic expression vectors and their expression in ovarian cancer cells

Construction of a vascular endothelial growth factor and sodium iodide symporter gene co-expressing eukaryotic vector

The Study of P53 Gene Therapy for Ovarian Cancer--construction of Recombinant Mammalian Expressing Vector for Human Wild-Type P53 Gene

[Construction of RegIα Over-Expression Vector and Its Effect on Proliferation and Apoptosis of Gastric Cancer Cells].

Construction of IRXI Eukaryotic Expression Vector and Its Sub-Cellular Localization in SGC-7901 Gastric Cancer Cell Line

Construction of Human Eukaryotic Vector with Expression of Survivin in K562 Cells

[Construction and Expression of Bisbicistronic Expression Vector of Novel Endocrine and Exocrine Protein Gene Associated with Breast Cancer and IRES Mediated Gene EGFP].

[Construction and Expression of a Novel Bisbicistronic Expression Vector: Pcmv-Myc-ires-egfp].

Construction of Eukaryotic Expression Vector Pires2-Egfp-v13kl and Its Expression in COS-7 Cells and Mouse Embryos

Construction of the vector with human P21 promoter and Dual-Luciferase reporter gene

Construction of MicroRNA-22 Eukaryotic Expression Vector and Stable Expression in Ovarian Cancer Cell Line SKOV-3

Construction of Eukaryote Polycistronic Expression Vector and Expression in Hela

Construction of Eukaryotic Expression Plasmid Pegfp-N3-m-il-2(88 Arg,125 Ala) and Its Effects on Glioma Cell Line U87

Construction of eukaryotic expressing vector of mouse PD-L1 and establishment of stable transfectant CHO cell line

Construction of pEGFP-N1-PRL-3 vector and its expression in SW480 cells

Construction of the Recombination Expression Vector Pires-Rb94 and Its Effect on Expression of SphK in Lung Adenocarcinoma A549 Cell Line

Construction and Identification of Pires2-Vegf165-nt-3 Bicistronic Eukaryotic Expression Vector.

Construction of Eukaryotic Vector for Expression of Tumor Suppress Gene WWOX in A549 Cells

Construction of a Recombinant Eukaryotic Expression Plasmid Containing Human PDLIM2 Gene and Its Biological Activity.